Center for Muscle Health and Neuromuscular Disorders
2014-2015 Presentation Schedule |
September 11th |
Priya Londhe, PhD (Guttridge Lab)
“Interferon gamma regulation of skeletal myogenesis”
Shibi Likhite (Kaspar Lab)
“AAV9-mediated gene therapy for therapeutic suppression
of mutant SOD1 in Amyotrophic Lateral Sclerosis”
|
NCH WA1525 |
October 9th |
Rui Xu PhD (Martin Lab)
“Identifying roles for endogenous Galgt2 gene expression in muscular dystrophy”
Sara Lampe, PhD (Foust Lab)
“SMN insufficiency causes defective neuromuscular signaling to GI smooth muscle” |
OSU DHLRI 165 |
November 13th |
Trainee Poster Day |
GRIGGS
BOATHOUSE |
December 11th |
Russell Hepple, PhD
McGill Research Centre for Physical Activity & Health
"High-throughput genetic screens to define the mechanisms of neurodegenerative disease" |
OSU DHLRI 165 |
January 8th |
Aaron Gitler, MD, PhD
Stanford University
"High-throughput genetic screens to define the mechanisms of neurodegenerative disease"
|
NCH WA1525 |
February 12th |
Stephen Kolb, MD, PhD.
Ohio State University
“Lessons learned from the NeuroNEXT Infant SMA Biomarker Study” |
OSU DHLRI 165 |
March 12th |
Louise Rodino-Klapac, PhD
Nationwide Children’s Hospital
"Gene replacement strategies for type 2 LGMDs" |
NCH WA1525 |
April 9th |
Matthew Husa, MD
Ohio State University
“The interaction of musculoskeletal tissues and immunity in age-associated osteoarthritis”
|
OSU DHLRI 165 |
May 14th |
Charlotte Sumner, PhD
John Hopkins University
Title: TBA |
NCH WA1525 |
| June 11th |
Heather Manring, PhD (Weisleder Lab)
"Increasing membrane repair as a therapy for Duchenne Muscular Dystrophy"
Joceyln Eidahl, PhD (Harper Lab)
“Protein Chemistry of Myotoxic DUX4” |
OSU DHLRI 165 |
